Miami Project to Cure Paralysis: This trial is an FDA-approved Phase I clinical trial designed to test the safety of autologous human Schwann cells in participants with chronic spinal cord injury receiving rehabilitation.A total of 10 participants will be enrolled in 2 cohorts.
Clinical trial testing autologous human Schwann cell transplantation for chronic SCI is open for enrollment:
Skip back to main navigation